Compare GSL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSL | SPRY |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | Greece | United States |
| Employees | 7 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 833.1M |
| IPO Year | N/A | 2020 |
| Metric | GSL | SPRY |
|---|---|---|
| Price | $38.56 | $8.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $43.50 | $40.00 |
| AVG Volume (30 Days) | 253.1K | ★ 1.4M |
| Earning Date | 05-18-2026 | 05-13-2026 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,278,000.00 |
| Revenue This Year | N/A | $90.76 |
| Revenue Next Year | N/A | $81.70 |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.77 | $6.66 |
| 52 Week High | $41.40 | $18.63 |
| Indicator | GSL | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 47.22 |
| Support Level | $36.82 | $8.05 |
| Resistance Level | $39.82 | $8.63 |
| Average True Range (ATR) | 0.92 | 0.37 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 62.82 | 55.36 |
Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.